Kym Michelle McCormick,Sneha Sethi,Dandara Haag et al.
Kym Michelle McCormick et al.
Objective: The COVID-19 pandemic significantly impacted and continues to impact the health and well-being of Australian adults. However, there has been no instrument validated to comprehensively measure how the COVID-19 p...
Clinical characteristics and treatment patterns of patients with episodic cluster headache: results from the United States, United Kingdom and Germany [0.03%]
美国、英国和德国丛集性头痛间歇期患者的临床特征及治疗模式
Sarah Cotton,Jeffrey S Andrews,Russell M Nichols et al.
Sarah Cotton et al.
Objective: To describe clinical characteristics and regional treatment patterns of episodic cluster headache (CH). Methods: A point-in-...
Enhancement and external validation of algorithms using diagnosis codes to identify invasive Escherichia coli disease [0.03%]
基于诊断编码识别侵袭性大肠杆菌疾病的算法的优化和外部验证
Luis Hernandez-Pastor,Jeroen Geurtsen,Antoine C El Khoury et al.
Luis Hernandez-Pastor et al.
Objective: To assess the predictive accuracy of code-based algorithms for identifying invasive Escherichia coli (E. coli) disease (IED) among inpatient encounters in US hospitals. ...
Adherence to levothyroxine treatment among patients with hypothyroidism in Oman: a national cross-sectional study [0.03%]
阿曼低甲状腺素血症患者的左旋甲状腺素治疗依从性全国横断面研究
Rahma Mohamed Al Kindi,Rahma Abdullah Al Riyami,Shahrazad Yahya Juma et al.
Rahma Mohamed Al Kindi et al.
Objective: Hormone replacement therapy with levothyroxine is considered the treatment of choice for hypothyroidism; however, non-adherence is a major contributor to poor treatment outcomes. This study aimed to evaluate le...
Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapy [0.03%]
非瓣膜性房颤患者停用口服抗凝药后的缺血性卒中和系统性栓塞事件
Mark J Alberts,Maryia Zhdanava,Dominic Pilon et al.
Mark J Alberts et al.
Objectives: To compare the risk of stroke and systemic embolism (SE) among patients with nonvalvular atrial fibrillation (NVAF) who abandoned their first direct oral anticoagulant (DOAC) fill ("abandoners") relative to pa...
Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies [0.03%]
美国老年人使用利伐沙班与华法林治疗房颤或急性静脉血栓栓塞的比较结果——观察性研究的系统评价
William L Baker,Matthew S Roberts,Youssef Bessada et al.
William L Baker et al.
Background: Advancing age is a risk factor for developing non-valvular atrial fibrillation (NVAF) or acute venous thromboembolism (VTE). We assessed the comparative effectiveness, safety, costs, and healthcare utilization...
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT [0.03%]
乙氧ascof仑/Formoterol与氟氯素铵/乌美溴铵/维兰特罗在慢性阻塞性肺疾病中的间接比较：基于ETHOS和IMPACT研究的匹配调整后的方法
Daiana Stolz,Erik Hermansson,Mario Ouwens et al.
Daiana Stolz et al.
Objective: Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. While two approved fixed-dose inhaled corticosteroid/long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) t...
Irisin, adropin, and preptin as biomarkers of energy dysregulation in depressive disorder [0.03%]
抑郁症的能量失调标志物——irisin、adropin和preptin
Mehmet Ali Cicek,Fatma Tuygar Okutucu,Nurinnisa Ozturk
Mehmet Ali Cicek
Objective: Lack of energy, fatigue, debility are often seen in depression and hardly respond to treatment. Finding some biomarkers for these symptoms may be important for diagnosis and treatment. We aimed to investigate t...
Correction [0.03%]
改正
Published Erratum
Current medical research and opinion. 2023 Sep;39(9):1287. DOI:10.1080/03007995.2023.2246730 2023
Long-term persistence and other treatment patterns among bio-naïve patients with Crohn's disease treated with ustekinumab or adalimumab [0.03%]
初治克罗恩病患者接受乌司奴单抗或阿达木单抗治疗的长期持续情况及其他治疗模式分析
Maryia Zhdanava,Zhijie Ding,Ameur M Manceur et al.
Maryia Zhdanava et al.
Objective: To estimate long-term persistence among bio-naïve patients with CD initiated on ustekinumab or adalimumab. Methods: Adults ...